Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2011 (Vol. 31, No. 20)

ASPicDB

URL:t.caspur.it/ASPicDB/
  • Links page to similar resources, simple layout
  • Nothing major

During processing, mRNA transcripts may be spliced to yield multiple final products; this phenomenon is known (appropriately enough) as alternative splicing. The tricky thing is, one cannot know how a transcript will be spliced simply by looking at the gene sequence…unless, of course, you have a handy, dandy alternative splicing fortune teller like ASPicDB (more formally, the Alternative Splicing Prediction Data Base). For each query, ASPicDB returns a gene structure view, predicted transcripts, a transcript table, predicted proteins, a protein table, predicted splice sites, and an intron table. There is also limited data regarding gene expression. If one alternative splicing prediction algorithm isn’t satisfying enough, one can check out (dare I say, alternative) splicing databases under the “useful links” tab. I predict you’ll find this site quite useful…

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »